Matches in Wikidata for { <http://www.wikidata.org/entity/Q50127619> ?p ?o ?g. }
- Q50127619 description "2017 nî lūn-bûn" @default.
- Q50127619 description "2017年の論文" @default.
- Q50127619 description "2017年学术文章" @default.
- Q50127619 description "2017年学术文章" @default.
- Q50127619 description "2017年学术文章" @default.
- Q50127619 description "2017年学术文章" @default.
- Q50127619 description "2017年学术文章" @default.
- Q50127619 description "2017年学术文章" @default.
- Q50127619 description "2017年學術文章" @default.
- Q50127619 description "2017年學術文章" @default.
- Q50127619 description "2017年學術文章" @default.
- Q50127619 description "2017年學術文章" @default.
- Q50127619 description "2017年學術文章" @default.
- Q50127619 description "2017년 논문" @default.
- Q50127619 description "article científic" @default.
- Q50127619 description "article scientific" @default.
- Q50127619 description "article scientifique" @default.
- Q50127619 description "articol științific" @default.
- Q50127619 description "articolo scientifico" @default.
- Q50127619 description "artigo científico" @default.
- Q50127619 description "artigo científico" @default.
- Q50127619 description "artigo científico" @default.
- Q50127619 description "artikel ilmiah" @default.
- Q50127619 description "artikull shkencor" @default.
- Q50127619 description "artikulong pang-agham" @default.
- Q50127619 description "artykuł naukowy" @default.
- Q50127619 description "artículo científico publicado en 2017" @default.
- Q50127619 description "artículu científicu" @default.
- Q50127619 description "bilimsel makale" @default.
- Q50127619 description "bài báo khoa học" @default.
- Q50127619 description "naučni članak" @default.
- Q50127619 description "scienca artikolo" @default.
- Q50127619 description "scientific article published on 31 August 2017" @default.
- Q50127619 description "scientific article published on 31 August 2017" @default.
- Q50127619 description "scientific article published on 31 August 2017" @default.
- Q50127619 description "teaduslik artikkel" @default.
- Q50127619 description "tieteellinen artikkeli" @default.
- Q50127619 description "tudományos cikk" @default.
- Q50127619 description "vedecký článok" @default.
- Q50127619 description "vetenskaplig artikel" @default.
- Q50127619 description "videnskabelig artikel" @default.
- Q50127619 description "vitenskapelig artikkel" @default.
- Q50127619 description "vitskapeleg artikkel" @default.
- Q50127619 description "vědecký článek" @default.
- Q50127619 description "wetenschappelijk artikel" @default.
- Q50127619 description "wissenschaftlicher Artikel" @default.
- Q50127619 description "επιστημονικό άρθρο" @default.
- Q50127619 description "мақолаи илмӣ" @default.
- Q50127619 description "наукова стаття, опублікована в серпні 2017" @default.
- Q50127619 description "научна статия" @default.
- Q50127619 description "научная статья" @default.
- Q50127619 description "научни чланак" @default.
- Q50127619 description "научни чланак" @default.
- Q50127619 description "מאמר מדעי" @default.
- Q50127619 description "مقالة علمية نشرت في 31 أغسطس 2017" @default.
- Q50127619 description "৩১ আগস্ট ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q50127619 description "บทความทางวิทยาศาสตร์" @default.
- Q50127619 description "სამეცნიერო სტატია" @default.
- Q50127619 name "Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib." @default.
- Q50127619 name "Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib." @default.
- Q50127619 type Item @default.
- Q50127619 label "Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib." @default.
- Q50127619 label "Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib." @default.
- Q50127619 prefLabel "Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib." @default.
- Q50127619 prefLabel "Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib." @default.
- Q50127619 P1433 Q50127619-697D5B15-EBA2-432F-9EA5-311B8D8D36DC @default.
- Q50127619 P1476 Q50127619-7FB18934-5AB4-48B9-93CB-79119381BC4E @default.
- Q50127619 P2093 Q50127619-1C0956AC-9F7E-4A87-8BB5-12DAC8CAECDF @default.
- Q50127619 P2093 Q50127619-1C916161-4D4F-49AE-AFEA-57F9604D2ED6 @default.
- Q50127619 P2093 Q50127619-3352470F-AEC5-4729-88D9-D0DEABCEE9FD @default.
- Q50127619 P2093 Q50127619-40F7610E-0174-4A30-8FB9-100EB776B3DC @default.
- Q50127619 P2093 Q50127619-42443AB0-1731-4C86-BF97-84E1E87EA7F5 @default.
- Q50127619 P2093 Q50127619-45FE2FF0-C04D-4FDE-80DC-CF88C8095F41 @default.
- Q50127619 P2093 Q50127619-5336752A-1D72-44E8-B6DD-3A80F88BC02E @default.
- Q50127619 P2093 Q50127619-8115B49C-603B-4F29-9AED-1C7E3D34C524 @default.
- Q50127619 P2093 Q50127619-8ED218CF-0485-451A-B06C-426179C6277C @default.
- Q50127619 P2093 Q50127619-CFF17453-23C0-447C-B108-A0543B0B85CD @default.
- Q50127619 P304 Q50127619-E4A591D2-EF3B-4947-B2E6-65DA3EFBE204 @default.
- Q50127619 P31 Q50127619-3EB834DA-A418-456E-AFDD-27ED67959323 @default.
- Q50127619 P356 Q50127619-73E7C942-0531-4D09-9CE3-7F14D94C62B1 @default.
- Q50127619 P478 Q50127619-7DCA0327-E529-4806-8D7D-AC729A89B0A6 @default.
- Q50127619 P50 Q50127619-3DB0CDDE-268D-462B-86E8-5F94F758FAAB @default.
- Q50127619 P50 Q50127619-F3F897FE-3109-482C-9F9D-64808A620C43 @default.
- Q50127619 P577 Q50127619-37455C61-B4AB-49BA-9A12-D3BB050D121B @default.
- Q50127619 P698 Q50127619-30401540-106C-4901-8E9B-AEF45E44F272 @default.
- Q50127619 P921 Q50127619-2249A4AB-A862-4B3F-8DED-B4BD47902EBF @default.
- Q50127619 P356 J.LUNGCAN.2017.08.014 @default.
- Q50127619 P698 29110849 @default.
- Q50127619 P1433 Q641464 @default.
- Q50127619 P1476 "Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib." @default.
- Q50127619 P2093 "Bushi Wang" @default.
- Q50127619 P2093 "D Ross Camidge" @default.
- Q50127619 P2093 "Egbert F Smit" @default.
- Q50127619 P2093 "Harry J M Groen" @default.
- Q50127619 P2093 "Jean Fan" @default.
- Q50127619 P2093 "Leora Horn" @default.
- Q50127619 P2093 "Matthias Freiwald" @default.
- Q50127619 P2093 "Vikram K Chand" @default.
- Q50127619 P2093 "Vincent A Miller" @default.
- Q50127619 P2093 "Yelena Y Janjigian" @default.